Lynch Regenerative Medicine
PrivateLast Round
Early Stage
VC
Jun 30, 2026
Total Funding Raised
$7.45M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Lynch Regenerative Medicine operates in Healthcare & Life Sciences and is based in Franklin, Tennessee. Its latest recorded funding round was a Series A round in July 2024.
Lynch Regenerative Medicine is a biotherapeutics company that develops and commercializes advanced skin rejuvenation and regeneration solutions using patented platelet-derived growth factor (PDGF) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lynch Regenerative Medicine Comparables
Compare Lynch Regenerative Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolarityBio, Inc. | 81% | |
| Merakris Therapeutics | 77% | |
| Theradaptive | 76% |
For institutional investors. Book with your work email.
Lynch Regenerative Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jun 30, 2026 | ||||
| Series A | Jul 16, 2024 | ||||
| Seed | Feb 1, 2024 | ||||
| Accelerator | Sep 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
$15M raised in early stage VC funding.
- Jun 11, 2026
Grew 19% QoQ, from 27 to 32 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 13, 2026
Lynch Regenerative Medicine, LLC. raises $15M in venture funding.
For institutional investors. Book with your work email.
Lynch Regenerative Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lynch Regenerative Medicine's valuation, stock price, and market status.
Is Lynch Regenerative Medicine a public or private company?
Lynch Regenerative Medicine is a private company.
What is the current stock price of Lynch Regenerative Medicine?
Lynch Regenerative Medicine is a private company, so its shares have no public market price. Caplight tracks Lynch Regenerative Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lynch Regenerative Medicine worth (valuation)?
Valuation information for Lynch Regenerative Medicine is not publicly available.
Can I buy Lynch Regenerative Medicine stock?
Lynch Regenerative Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lynch Regenerative Medicine's last funding round?
Lynch Regenerative Medicine's most recent funding round was Early Stage VC on June 30, 2026.
Who are the main investors in Lynch Regenerative Medicine?
Investor information for Lynch Regenerative Medicine is not publicly disclosed.
Will Lynch Regenerative Medicine IPO soon?
No public IPO plans have been announced for Lynch Regenerative Medicine.
How can I track Lynch Regenerative Medicine secondary market activity?
Caplight tracks bids, offers, and trades in Lynch Regenerative Medicine's shares on secondary markets.